Context Navigation

← Previous Revision
Latest Revision
Next Revision →
Blame
Revision Log

WV-DIALOG-0246.txt@ 1727

Last change on this file since 1727 was 604, checked in by George Lilly, 15 years ago
Internationalization
File size: 7.9 KB

Line
1	English French Notes Complete/Exclude
2	DATE OF LAST CONTACT:
3	TUMOR STATUS:
4	ICD Revision:
5	Place of Death:
6	Care Center at Death:
7	Autopsy:
8	Autopsy Date/Time:
9	Autopsy No:
10	ICD Cause of Death:
11	Cause of Death/Cancer:
12	Date of Death:
13	Path/autopsy:
14	Religion:
15	Marital Status at Dx:
16	Occupation:
17	Last Date:
18	Type of Tobacco user:
19	YR. Quit Tobacco Use:
20	Yrs. of Alcohol Use:
21	Drinks per-day:
22	Yr. Quit Drinking:
23	Family Member with Cancer:
24	Cancer:
25	Primary Surgeon:
26	Managing Physician:
27	Following Physician:
28	Other Physician 3:
29	Other Physician 4:
30	DX Date:
31	Class of Case:
32	Type of Reporting Source:
33	Histology:
34	Dx Facility:
35	Text Histology:
36	Grade:
37	Tumor Marker 2:
38	ICDO-Site:
39	Referring Facility:
40	Laterality:
41	Transfer Facility:
42	DX Confirmation:
43	Primary Payer at Diagnosis:
44	IP/OP status:
45	Screening Result:
46	Screening Date:
47	Presentation at Cancer Conference:
48	Date of Cancer Conference:
49	Referral to Support Services:
50	Site/Gp:
51	Primary Sequence No:
52	Text-Primary Site Title:
53	Text-Dx Proc-PE:
54	Text-Dx Proc-X-ray/scan:
55	Text-Dx Proc-Op:
56	Text-Dx Proc-Lab Tests:
57	Text-Dx Proc-Scopes:
58	Text-Dx Proc-Path:
59	Text Primary Site:
60	Text Dx Proc-Phys.Exam:
61	Text Dx Proc-Xray/Scan:
62	Text Dx Proc-Operation:
63	Text Dx Proc-Lab Tests:
64	Text Dx Proc-Endoscopy:
65	Text Dx Proc-Path/Cyto:
66	Clinical TNM:
67	Clinical T:
68	Pathologic T:
69	Clinical N:
70	Pathologic N:
71	Clinical M:
72	Pathologic M:
73	Clinical Stage Group:
74	Staged By (Clin):
75	Other Stage:
76	Size of Tumor:
77	Positive nodes:
78	Peripheral Blood Inv.:
79	Nodes Examined:
80	Associated with HIV:
81	Extension:
82	Metastasis-1:
83	Lymph Nodes:
84	Metastasis-2:
85	General Summary Stage:
86	Metastasis-3:
87	Dx/Stging/Palliative Proc:
88	Surgery of Primary Site Date:
89	Surgical Approach:
90	Reconstruction/Restoration:
91	- Text Rx-Surgery/No Surgery:
92	- Text Rx-Other Cancer Directed Surgery:
93	Surgical Margins:
94	Reason for No Surgery:
95	Radiation Date:
96	Regional Dose:
97	Radiation tx not administered
98	NA, brachytherapy/radioisotopes administered
99	Dose unknown/unknown if administered
100	Regional Treatment Modality:
101	Reason for No Radiation:
102	Sequence:
103	Radiation Treatment - (either radiation or prophylactic)
104	Target Place:
105	Target Site:
106	Radiation Source:
107	Total due to target:
108	Predominant FXN size:
109	Start Date:
110	Stop Date:
111	- Text Rx-Rad (BEAM):
112	- Text Rx-Rad-Other:
113	Radiation Therapy to CNS DAte:
114	Chemotherapy Date:
115	Reason for No Chemotherapy:
116	Text-Rx-Chemo:
117	Hormone Therapy Date:
118	Reason for No Hormone Therapy:
119	Text-Rx-Hormone:
120	Immunotherapy Date:
121	Text-RX-Immunotherapy:
122	Other Therapy Date:
123	Text-Rx-Other:
124	Protocol Eligibility Status:
125	Protocol Participation:
126	Text Remarks:
127	Physician's Staging:
128	MD:
129	QA Selected:
130	QA Review:
131	QA Date:
132	Recurrence Date:
133	Distant Site 1:
134	Type of 1st Recurrence:
135	Distant Site 2:
136	Distant Site 3:
137	Subsequent Recurrence Date:
138	Type of Subsequent Recurrence:
139	******** Print Abstract-Brief ********
140	Reporting Hospital:
141	Date of First Contact:
142	Histology:
143	Acc/Seq Number:
144	Medical Record Number:
145	Telephone:
146	Type of Reporting Source:
147	Class of Case:
148	Age at Dx:
149	Birthplace:
150	Facility referred from:
151	Facility referred to:
152	Date Dx:
153	Following physician:
154	Primary surgeon:
155	Physician #3:
156	Physician #4:
157	Laterality:
158	Diagnostic confirmation:
159	Tumor size:
160	Extension:
161	Regional lymph nodes positive:
162	Regional lymph nodes examined:
163	Lymph nodes:
164	SEER Summary Stage 2000:
165	Sites of metastases:
166	Clinical TNM:
167	AJCC Stage (Clin):
168	AJCC Stage (Path):
169	FIRST COURSE OF TREATMENT SUMMARY:
170	Dx/Staging/Palliative Proc:
171	Surgery of primary site:
172	Reason for no surgery:
173	Radiation:
174	Reason for no radiation:
175	Hormone Therapy:
176	Immunotherapy:
177	Other treatment:
178	Abstract Date:
179	Abstracter:
180	Date of Last Patient Contact:
181	AVAILABLE CONTACTS
182	*********DEATH INFORMATION********
183	Date:
184	Cause of Death/Cancer:
185	ICD Cause:
186	Care Center:
187	ICD Revision:
188	Path/Autopsy (Gross & Micro):
189	State Hospital No:
190	IDCO SITE:
191	GRADE:
192	Sequence Number:
193	DATE of LAST CONTACT:
194	VITAL STATUS:
195	ABSTRACTER:
196	ABSTRACT DATE:
197	Spanish origin:
198	CONTACT NAME
199	Follow-up Status:
200	DATE LAST
201	Site/Gp:
202	PATIENT SUMMARY
203	Date of Last Contact or Death:
204	Autopsy Date/Time:
205	Autopsy #:
206	Cause of Death:
207	Abstract Status:
208	Date Case Completed:
209	Primary Site:
210	Patient Summary/Abstract for:
211	PATIENT IDENTIFICATION
212	Address at Dx:
213	Accession No:
214	Hospital No:
215	Accession Yr:
216	Primary Sequence No:
217	Phone Residence:
218	Marital Status DX:
219	Agent Orange Exp:
220	Ionizing Rad Exp:
221	Chemical Exp:
222	Asbestos Exp:
223	Persian Gulf Svc:
224	Middle East Svc:
225	Somalia Svc:
226	Comorbidity/Complication #1:
227	Comorbidity/Complication #2:
228	Comorbidity/Complication #3:
229	Comorbidity/Complication #4:
230	Comorbidity/Complication #5:
231	Comorbidity/Complication #6:
232	Primary Surgeon:
233	Following Physician:
234	CANCER IDENTIFICATION
235	Date DX:
236	Histology:
237	AFIP Submission:
238	Primary Site:
239	STAGE OF DISEASE AT DIAGNOSIS
240	Clinical TNM:
241	Pathologic TNM:
242	Clinical Stage Group:
243	Pathologic Stage Group:
244	Staged By (Clinical Stage):
245	Staged By (Pathologic Stage):
246	Other Stage:
247	Pathologic Extension:
248	Lymph Nodes:
249	General Summary Stage:
250	Metastasis-1:
251	Metastasis-2:
252	Metastasis-3:
253	FIRST COURSE OF TREATMENT
254	First Course of Treatment Date:
255	Date of No Treatment:
256	Surgery of Primary (F):
257	Surgery of Primary @Fac (F):
258	Surgical Margins:
259	Scope of LN Surgery (F):
260	Scope of LN Surgery @Fac (F):
261	Surg Proc/Other Site (F):
262	Surg Proc/Other Site @Fac (F):
263	Reason for No Surgery:
264	Regional Dose:
265	Regional Treatment Modality:
266	Chemotherapy:
267	Chemotherapy @Fac:
268	Hormone Therapy:
269	Hormone Therapy @Fac:
270	Immunotherapy:
271	Immunotherapy @Fac:
272	Other Treatment:
273	Other Treatment @Fac:
274	Year Put on Protocol:
275	SUBSEQUENT THERAPY
276	Subsequent Treatment Date:
277	Surgery of Primary Site:
278	Hema Trans/Endocrine Proc:
279	FOLLOW-UP HISTORY
280	Cause of Death:
281	1998 Patient Care Evaluation Study of Prostate Cancer
282	1998 Patient Care Evaluation Study of Prostate Cancer
283	8. PRIMARY PAYER AT DIAGNOSIS
284	9. FAMILY HISTORY OF PROSTATE CANCER
285	8. PRIMARY PAYER AT DIAGNOSIS
286	9. FAMILY HISTORY OF PROSTATE CANCER
287	TABLE I - GENERAL INFORMATION
288	9 4. POSTAL CODE AT DIAGNOSIS.........
289	9 7. SPANISH ORIGIN...................
290	18 8. PRIMARY PAYER AT DIAGNOSIS.......
291	657 9. FAMILY HISTORY OF PROSTATE CANCER
292	10. CLASS OF CASE
293	11. SYMPTOMS PRESENT AT INITIAL DIAGNOSIS
294	12. INITIAL METHODS OF DIAGNOSIS
295	13. DIAGNOSTIC EVALUATION
296	14. RESULTS OF MOST RECENT PRE-TREATMENT PSA TEST
297	18. BEHAVIOR CODE(ICD-O-2)
298	20. BIOPSY PROCEDURE
299	21. GUIDANCE OF BIOPSY TO PRIMARY
300	22. BIOPSY APPROACH FOR PRIMARY
301	23. BIOPSY OF OTHER THAN PRIMARY
302	24. DIAGNOSTIC CONFIRMATION
303	#################### #################### ####################
304	#################### #################### ####################
305	#################### #################### ####################
306	#################### #################### ####################
307	#################### #################### ####################

Note: See TracBrowser for help on using the repository browser.

Context Navigation

source: internationalization/trunk/TranslationSpreadsheets/WV-DIALOG-0246.txt@ 1727

Download in other formats: